Tokyo, Feb. 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060537) titled 'Development of an Artificial Intelligence Based Diagnostic Support System for Endoscopic Remission in Ulcerative Colitis' on Jan. 31.
Study Type:
Observational
Primary Sponsor:
Institute - Showa Medical University Northern Yokohama Hospital
Condition:
Condition - Ulcerative colitis
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - The objective of this study is to improve the diagnostic accuracy and evaluate the generalizability of an artificial intelligence-based software system for endoscopic remission in ulcerative colitis using colonoscopy images collected from multiple institutions. This study aims to establish a standardized diagnostic support system independent of endoscopist experience.
Basic objectives2 - Efficacy
Eligibility:
Age-lower limit - 20
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Patients aged 20 years or older with a confirmed diagnosis of ulcerative colitis who undergo colonoscopy as part of routine clinical practice.
Key exclusion criteria - Patients who refuse to participate in this study
Target Size - 1300
Recruitment Status:
Recruitment status - Open public recruiting
Date of protocol fixation - 2021 Year 03 Month 29 Day
Date of IRB - 2021 Year 05 Month 31 Day
Anticipated trial start date - 2021 Year 06 Month 01 Day
Last follow-up date - 2026 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069248
Disclaimer: Curated by HT Syndication.
